New Releases from NCBI BookshelfSparsentan for treating primary IgA nephropathy.Sparsentan for treating primary IgA nephropathy.
Post Content
Uncategorized
Uncategorized
New Releases from NCBI BookshelfExtracorporeal carbon dioxide removal for the treatment of acute hypoxaemic respiratory failure: the REST RCT.Extracorporeal carbon dioxide removal for the treatment of acute hypoxaemic respiratory failure: the REST RCT.
In patients who require mechanical ventilation for acute hypoxaemic respiratory failure, further reduction in tidal volumes, compared with conventional low
Uncategorized
New Releases from NCBI BookshelfComparing Telehealth and Clinic-Based Care for Lowering Uncontrolled High Blood Pressure [Internet].Comparing Telehealth and Clinic-Based Care for Lowering Uncontrolled High Blood Pressure [Internet].
Approximately 1 in 3 American adults has hypertension. Lowering blood pressure (BP) to recommended levels has been shown to reduce
Uncategorized
New Releases from NCBI BookshelfAntiviral Drugs for Post-Exposure Prophylaxis Against Influenza A or Influenza B: Drugs [Internet].Antiviral Drugs for Post-Exposure Prophylaxis Against Influenza A or Influenza B: Drugs [Internet].
Antiviral medications for influenza can be used after exposure but before symptom onset to reduce the occurrence of symptomatic and
Uncategorized
New Releases from NCBI BookshelfPembrolizumab (Keytruda): Indication: For the treatment of adult patients with primary advanced or recurrent endometrial carcinoma, in combination with carboplatin and paclitaxel and then continued as monotherapy: Reimbursement Recommendation [Internet].Pembrolizumab (Keytruda): Indication: For the treatment of adult patients with primary advanced or recurrent endometrial carcinoma, in combination with carboplatin and paclitaxel and then continued as monotherapy: Reimbursement Recommendation [Internet].
Canada’s Drug Agency (CDA-AMC) recommends that Keytruda be reimbursed by public drug plans for the treatment of primary advanced or
Uncategorized
New Releases from NCBI BookshelfPoint-of-Care Ultrasound for Guided Central Venous Catheter Insertion Compared to the Landmark Method: Health Technologies [Internet].Point-of-Care Ultrasound for Guided Central Venous Catheter Insertion Compared to the Landmark Method: Health Technologies [Internet].
Conventional central line insertion technique using the landmark method to identify the target vein for catheter insertion does not account
Uncategorized
New Releases from NCBI BookshelfCerliponase Alfa for Pediatric Patients With Neuronal Ceroid Lipofuscinosis Type 2 Disease: Drugs [Internet].Cerliponase Alfa for Pediatric Patients With Neuronal Ceroid Lipofuscinosis Type 2 Disease: Drugs [Internet].
Neuronal ceroid lipofuscinosis type 2 (CLN2) disease is an ultrarare, severe, and rapidly progressing lysosomal storage disorder, with a global
